UNIGE document Scientific Article
previous document  unige:7371  next document
add to browser collection

Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy

Kaufmann, G. R.
Furrer, Hansjakob
Ledergerber, Bruno
Opravil, Milos
Vernazza, Pietro
Cavassini, Matthias
show hidden authors show all authors [1 - 11]
Published in Clinical infectious diseases. 2005, vol. 41, no. 3, p. 361-372
Abstract BACKGROUND: The CD4 T cell count recovery in human immunodeficiency virus type 1 (HIV-1)-infected individuals receiving potent antiretroviral therapy (ART) shows high variability. We studied the determinants and the clinical relevance of incomplete CD4 T cell restoration. METHODS: Longitudinal CD4 T cell count was analyzed in 293 participants of the Swiss HIV Cohort Study who had had a plasma HIV-1 RNA load <1000 copies/mL for > or =5 years. CD4 T cell recovery was stratified by CD4 T cell count 5 years after initiation of ART (> or =500 cells/microL was defined as a complete response, and <500 cells/microL was defined as an incomplete response). Determinants of incomplete responses and clinical events were evaluated using logistic regression and survival analyses. RESULTS: The median CD4 T cell count increased from 180 cells/microL at baseline to 576 cells/microL 5 years after ART initiation. A total of 35.8% of patients were incomplete responders, of whom 47.6% reached a CD4 T cell plateau <500 cells/microL. Centers for Disease Control and Prevention HIV-1 disease category B and/or C events occurred in 21% of incomplete responders and in 14.4% of complete responders (P>.05). Older age (adjusted odds ratio [aOR], 1.71 per 10-year increase; 95% confidence interval [CI], 1.21-2.43), lower baseline CD4 T cell count (aOR, 0.37 per 100-cell increase; 95% CI, 0.28-0.49), and longer duration of HIV infection (aOR, 2.39 per 10-year increase; 95% CI, 1.19-4.81) were significantly associated with a CD4 T cell count <500 cells/microL at 5 years. The median increases in CD4 T cell count after 3-6 months of ART were smaller in incomplete responders (P<.001) and predicted, in conjunction with baseline CD4 T cell count and age, incomplete response with 80% sensitivity and 72% specificity. CONCLUSION: Individuals with incomplete CD4 T cell recovery to <500 cells/microL had more advanced HIV-1 infection at baseline. CD4 T cell changes during the first 3-6 months of ART already reflect the capacity of the immune system to replenish depleted CD4 T lymphocytes.
Keywords AdultAnti-HIV Agents/ therapeutic useCD4 Lymphocyte CountCD8-Positive T-LymphocytesCohort StudiesFemaleHIV Infections/ drug therapyHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisOdds RatioRNA, Viral/bloodRisk FactorsTime FactorsViral Load
PMID: 16007534
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
KAUFMANN, G. R. et al. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. In: Clinical infectious diseases, 2005, vol. 41, n° 3, p. 361-372. doi: 10.1086/431484 https://archive-ouverte.unige.ch/unige:7371

469 hits

0 download


Deposited on : 2010-06-21

Export document
Format :
Citation style :